Tag: ReverseIT
Valbiotis announces the last visit of the last patient of the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science – 03/13/2023 at 17:40
• The last patient included in the study completed the last follow-up visit planned by the protocol. • The first results of the study will be communicated before the end…
Valbiotis announces the last visit of the last patient included in the Reverse-IT study – 03/13/2023 at 18:22
(AOF) – Valbiotis, a biotech company specializing in the prevention and fight against metabolic and cardiovascular diseases, announces the last visit of the last patient included in the Phase II/III…